NEW YORK, June 19, 2018 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Flex Pharma, Inc. (“Flex Pharma” or the “Company”) (NASDAQ:FLKS) and certain of its officers. The class action, filed in United States …
Go to Source